122 related articles for article (PubMed ID: 4715992)
1. Pharmacological modifications of the 6-hydroxy-dopa induced degeneration of central noradrenaline neurons.
Jonsson G; Sachs C
Biochem Pharmacol; 1973 Jul; 22(14):1709-16. PubMed ID: 4715992
[No Abstract] [Full Text] [Related]
2. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
Sachs C; Jonsson G
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
[No Abstract] [Full Text] [Related]
3. 6-Aminodopamine-induced degeneration of catecholamine neurons.
Jonsson G; Sachs C
J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
[No Abstract] [Full Text] [Related]
4. Effect of dopa on the norepinephrine and dopamine contents and on the granulated vesicles of the hypothalamus of reserpinized rabbits.
Hashimoto Y; Ishii S; Ohi Y; Shimizu N; Imaizumi R
Jpn J Pharmacol; 1965 Dec; 15(4):395-400. PubMed ID: 5296051
[No Abstract] [Full Text] [Related]
5. [Selective concentration of dopamine in the parenchyma of the rat brain].
Constantinidis J; Bartholini G; Tissot R; Pletscher A
Helv Physiol Pharmacol Acta; 1967; 25(4):CR411+. PubMed ID: 5586884
[No Abstract] [Full Text] [Related]
6. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
Sachs C; Jonsson G
J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
[No Abstract] [Full Text] [Related]
7. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
Jonsson G; Lohmander S; Sachs C
Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
[No Abstract] [Full Text] [Related]
8. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat.
Carr LA; Moore KE
Biochem Pharmacol; 1970 Jul; 19(7):2361-74. PubMed ID: 5520379
[No Abstract] [Full Text] [Related]
9. Detailed noradrenaline pathways of locus coeruleus neuron to the cerebral cortex with use of 6-hydroxydopa.
Toyama M; Maeda T; Shimizu N
Brain Res; 1974 Oct; 79(1):139-44. PubMed ID: 4425949
[No Abstract] [Full Text] [Related]
10. Synthesis and release of noradrenaline and dopamine from discrete regiions of monkey brain.
Roth RH; Allikmets L; Delgado JM
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):273-82. PubMed ID: 4997253
[No Abstract] [Full Text] [Related]
11. [Variations of monoamines induced by p-chloro N-methylamphetamine in different parts of the rat brain].
Boissier JR; Simon P; Guernet M; Tillement JP
C R Acad Hebd Seances Acad Sci D; 1969 May; 268(18):2298-300. PubMed ID: 4980248
[No Abstract] [Full Text] [Related]
12. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
Thoa NB; Eichelman B; Ng LK
Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
[No Abstract] [Full Text] [Related]
13. Selective 6-hydroxy-DOPA induced degeneration of central and peripheral noradrenaline neurons.
Sachs C; Jonsson G
Brain Res; 1972 May; 40(2):563-8. PubMed ID: 5027179
[No Abstract] [Full Text] [Related]
14. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
Sachs C; Jonsson G
J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
[No Abstract] [Full Text] [Related]
15. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
Schoenfeld RI; Uretsky NJ
J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
[No Abstract] [Full Text] [Related]
16. Unstimulated and amphetamine-stimulated release of endogenous noradrenaline and dopamine from rat brain in vivo.
Philips SR; Robson AM; Boulton AA
J Neurochem; 1982 Apr; 38(4):1106-10. PubMed ID: 7062033
[TBL] [Abstract][Full Text] [Related]
17. Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.
Javoy F; Hamon M; Glowinski J
Eur J Pharmacol; 1970 May; 10(2):178-88. PubMed ID: 4393431
[No Abstract] [Full Text] [Related]
18. Effects of chronically administered L-dopa in normal and lesioned cats.
Langelier P; Roberge AG; Boucher R; Poirier LJ
J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
[No Abstract] [Full Text] [Related]
19. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
[No Abstract] [Full Text] [Related]
20. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
Rutledge CO; Azzaro AJ; Ziance RJ
Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
